Clinical Efficacy Patients receiving AOMs were considered to achieve the mean weight loss and cardiometabolic benefits observed during the first 2 years of clinical trials, including improvements in body weight, systolic blood pressure, diastolic blood pressure, fasting glucose, total cholesterol, high-density lipoprotein cholesterol, and triglycerides (eTable 1 in Supplement 1)
Your choice depends on your specific goals, risk tolerance, and preference for newer versus established compounds
Ishii KB, Chang B, Kerwin JF, et al
The close interrelationship between MASLD and T2DM creates a self-perpetuating vicious cycle that amplifies the risk of both hepatic and extrahepatic complications, including fatal and nonfatal CVD events and chronic kidney disease, which are major causes of morbidity and mortality in this patient population (as summarized in Figure 3(Fig
For clean, precise growth hormone pulses with virtually no unwanted hormonal noise, I lean towards Ipamorelin
BPC-157 may increase collagen production, an important protein for connective tissue repair